Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 95.06 Billion KRW | -67.72% |
| 2022 | 294.47 Billion KRW | 43.51% |
| 2021 | 205.19 Billion KRW | -8.16% |
| 2020 | 223.42 Billion KRW | 36.72% |
| 2019 | 163.41 Billion KRW | 91.42% |
| 2018 | 85.37 Billion KRW | 32.76% |
| 2017 | 64.3 Billion KRW | 115.14% |
| 2016 | 29.89 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 110.66 Billion KRW | 11.86% |
| 2024 Q1 | 98.93 Billion KRW | -30.2% |
| 2023 Q1 | 324.37 Billion KRW | 10.16% |
| 2023 FY | 95.06 Billion KRW | -67.72% |
| 2023 Q4 | 141.74 Billion KRW | -58.7% |
| 2023 Q3 | 343.23 Billion KRW | 2.65% |
| 2023 Q2 | 334.37 Billion KRW | 3.08% |
| 2022 Q2 | 268.94 Billion KRW | 13.02% |
| 2022 Q4 | 294.47 Billion KRW | -9.23% |
| 2022 Q3 | 324.43 Billion KRW | 20.63% |
| 2022 FY | 294.47 Billion KRW | 43.51% |
| 2022 Q1 | 237.95 Billion KRW | 15.97% |
| 2021 Q3 | 203.05 Billion KRW | 0.0% |
| 2021 Q4 | 205.19 Billion KRW | 1.05% |
| 2021 FY | 205.19 Billion KRW | -8.16% |
| 2020 FY | 223.42 Billion KRW | 36.72% |
| 2019 FY | 163.41 Billion KRW | 91.42% |
| 2018 FY | 85.37 Billion KRW | 32.76% |
| 2017 FY | 64.3 Billion KRW | 115.14% |
| 2016 FY | 29.89 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| HLB Co., Ltd. | 17.93 Billion KRW | -430.121% |
| iNtRON Biotechnology, Inc. | 258.29 Million KRW | -36705.914% |
| BINEX Co., Ltd. | 5.57 Billion KRW | -1604.226% |
| Bioneer Corporation | 12.5 Billion KRW | -660.542% |
| Anterogen.Co.,Ltd. | - KRW | -Infinity% |
| MEDIPOST Co., Ltd. | 6.99 Billion KRW | -1259.098% |
| CrystalGenomics, Inc. | 29.88 Billion USD | -218.067% |
| Helixmith Co., Ltd | 151.68 Million KRW | -62576.546% |
| Medy-Tox Inc. | 1.22 Billion KRW | -7655.306% |
| Peptron, Inc. | 4.5 Billion KRW | -2012.617% |
| Amicogen, Inc. | 70.65 Billion KRW | -34.554% |
| Genexine, Inc. | 22.68 Billion KRW | -319.144% |
| HLB Therapeutics Co.,Ltd. | 1.84 Billion KRW | -5066.194% |
| LegoChem Biosciences, Inc. | 528.37 Million KRW | -17892.562% |
| ALTEOGEN Inc. | 1.24 Billion KRW | -7509.946% |
| PharmaResearch Co., Ltd. | 970.71 Million KRW | -9693.562% |
| SillaJen, Inc. | 8.13 Billion KRW | -1068.505% |
| JETEMA, Co., Ltd. | 60 Billion KRW | -58.446% |
| OliX Pharmaceuticals,Inc | 35.36 Billion KRW | -168.844% |
| Genomictree Inc. | 97.51 Million KRW | -97389.762% |
| MedPacto, Inc. | 1.68 Billion KRW | -5535.497% |
| D&D Pharmatech | 5.12 Billion KRW | -1756.567% |
| EASY BIO,Inc. | 30 Billion KRW | -216.893% |
| GI Innovation, Inc. | 2.9 Billion KRW | -3173.676% |